Atlas Trials

Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection

Clinical trial NCT06585020 · RECRUITING

Trial details

NCT number
NCT06585020
Sponsor
Centre Hospitalier Universitaire, Amiens
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Mycobacterium; XenopiLung Diseases
Start date
2024-10-20
Primary completion
2026-08-01
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.